The Critical Bridge Between Innovation and Market CDMOs act as the essential bridge connecting pharmaceutical research ...
SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces ...
WuXi XDC, China-based contract research, development and manufacturing organisation (CRDMO) focused on antibody drug con...
South Korean firm Lotte Biologics has recently signed a strategic business agreement with NJ Bio (hereinafter refer...
Japan-based Fujirebio Holdings and Indian firm Agappe Diagnostics have entered into an agreement of Contract Development...
Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of Upsher-Smith L...
China's WuXi Biologics has signed a research service agreement with Germany-based BioNTech SE, a next generation immunot...
How is the contract manufacturing/development sector evolving in Korea? How is West leveraging opportunities in this spa...
AGC Inc, Japan-headquartered manufacturer of glass, chemicals, and high-tech materials, has decided to expand its biopha...
Japan-headquartered Fujifilm Corporation has announced the investment of $200 million in two subsidiaries to significant...
Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics...
Samsung Biologics, South Korea-based contract development and manufacturing organisation (CDMO), and Kurma Partners, a E...
WuXi XDC, a China-based Contract, Research, Development, Manufacturing Organisation (CRDMO) focused on the antibody drug...
Thermo Fisher Scientific has expanded its manufacturing capacity in St. Louis, US to support biologic therapies for dise...
Lotte Biologics has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) for the establ...
WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...
China-based startup Canton Biologics recently completed a Series C financing round exceeding 300 million yuan. This roun...
Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva ...
